跳至主要内容
临床试验/IRCT2016042227520N1
IRCT2016042227520N1已完成2 期

The effects of oral nanocurcumin on expression levels of microRNAs and Treg cells and Th17 cells development factors in Multiple Sclerosis patients

Drug Applied Research Center0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
28 years 至 51 years(—)
性别
All

入选标准

  • Willingness to cooperate;
  • Ranging in age from 28 to 51 years
  • MS diagnosis by neurologist
  • patients in relapse and remitting

排除标准

  • Used nutritional supplements and antioxidants and alpha lipoic acid within a month before the study
  • Pregnancy and lactation;
  • History of diabetes and other chronic diseases;
  • History of other autoimmune disease;
  • corticosteroid use during illness;
  • the occurrence of relapses during the study phase;
  • acceptance rate of less than 70% of supplements;
  • not wanting to continue cooperation.

研究者

发起方
Drug Applied Research Center

相似试验